AAAAAA
Results:
1-22
|
Results: 22
Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid
Authors:
Ahrens, T
Sleeman, JP
Schempp, CM
Howells, N
Hofmann, M
Ponta, H
Herrlich, P
Simon, JC
Citation: T. Ahrens et al., Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid, ONCOGENE, 20(26), 2001, pp. 3399-3408
Authors:
Herrlich, P
Citation: P. Herrlich, Cross-talk between glucocorticoid receptor and AP-1, ONCOGENE, 20(19), 2001, pp. 2465-2475
Authors:
Morrison, H
Sherman, LS
Legg, J
Banine, F
Isacke, G
Haipek, CA
Gutmann, DH
Ponta, H
Herrlich, P
Citation: H. Morrison et al., The NF2 tumor suppressor gene product, merlin, mediates contact inhibitionof growth through interactions with CD44, GENE DEV, 15(8), 2001, pp. 968-980
Authors:
Weg-Remers, S
Ponta, H
Herrlich, P
Konig, H
Citation: S. Weg-remers et al., Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway, EMBO J, 20(15), 2001, pp. 4194-4203
Authors:
Ahrens, T
Assmann, V
Fieber, C
Termeer, CC
Herrlich, P
Hofmann, M
Simon, JC
Citation: T. Ahrens et al., CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation, J INVES DER, 116(1), 2001, pp. 93-101
Authors:
Wallach-Dayan, SB
Grabovsky, V
Moll, J
Sleeman, J
Herrlich, P
Alon, R
Naor, D
Citation: Sb. Wallach-dayan et al., CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes, J CELL SCI, 114(19), 2001, pp. 3463-3477
Authors:
Nestl, A
Von Stein, OD
Zatloukal, K
Thies, WG
Herrlich, P
Hofmann, M
Sleeman, JP
Citation: A. Nestl et al., Gene expression patterns associated with the metastatic phenotype in rodent and human tumors, CANCER RES, 61(4), 2001, pp. 1569-1577
Authors:
Rochman, M
Moll, J
Herrlich, P
Wallach, SB
Nedvetzki, S
Sionov, RV
Golan, I
Ish-Shalom, D
Naor, D
Citation: M. Rochman et al., The CD44 receptor of lymphoma cells: Structure-function relationships and mechanism of activation, CELL AD COM, 7(4), 2000, pp. 331-347
Authors:
Blattner, C
Kannouche, P
Litfin, M
Bender, K
Rahmsdorf, HJ
Angulo, JF
Herrlich, P
Citation: C. Blattner et al., UV-induced stabilization of c-fos and other short-lived mRNAs, MOL CELL B, 20(10), 2000, pp. 3616-3625
Authors:
Knebel, A
Bohmer, FD
Herrlich, P
Citation: A. Knebel et al., Radiation-induced signal transduction, METH ENZYM, 319, 2000, pp. 255-272
Authors:
Matter, N
Marx, M
Weg-Remers, S
Ponta, H
Herrlich, P
Konig, H
Citation: N. Matter et al., Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways, J BIOL CHEM, 275(45), 2000, pp. 35353-35360
Authors:
Herrlich, P
Bohmer, FD
Citation: P. Herrlich et Fd. Bohmer, Redox regulation of signal transduction in mammalian cells, BIOCH PHARM, 59(1), 2000, pp. 35-41
Authors:
Ponta, H
Herrlich, P
Citation: H. Ponta et P. Herrlich, The CD44 protein family: Roles in embryogenesis and tumor progression, PEDIAT PATH, 18(4-5), 1999, pp. 381-393
Authors:
Blattner, C
Tobiasch, E
Litfen, M
Rahmsdorf, HJ
Herrlich, P
Citation: C. Blattner et al., DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation, ONCOGENE, 18(9), 1999, pp. 1723-1732
Authors:
Sherman, L
Sleeman, JP
Hennigan, RF
Herrlich, P
Ratner, N
Citation: L. Sherman et al., Overexpression of activated neu/erbB2 initiates immortalization and malignant transformation of immature Schwann cells in vitro, ONCOGENE, 18(48), 1999, pp. 6692-6699
Authors:
Sleeman, JP
Kim, U
LePendu, J
Howells, N
Coquerelle, T
Ponta, H
Herrlich, P
Citation: Jp. Sleeman et al., Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B, ONCOGENE, 18(31), 1999, pp. 4485-4494
Authors:
Milde, KF
Herrlich, P
Ponta, H
Citation: Kf. Milde et al., CD44 splice variants in draining lymph nodes precede allograft rejection of endocrine cells, J MOL MED-J, 77(1), 1999, pp. 67-69
Authors:
Herrlich, P
Bender, K
Knebel, A
Bohmer, FD
Gross, S
Blattner, C
Rahmsdorf, HJ
Gottlicher, M
Citation: P. Herrlich et al., Radiation-induced signal transduction. Mechanisms and consequences, CR AC S III, 322(2-3), 1999, pp. 121-125
Authors:
Gross, S
Knebel, A
Tenev, T
Neininger, A
Gaestel, M
Herrlich, P
Bohmer, FD
Citation: S. Gross et al., Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction, J BIOL CHEM, 274(37), 1999, pp. 26378-26386
Authors:
Foekens, JA
Dall, P
Klijn, JGM
Skroch-Angel, P
Claassen, CJC
Look, MP
Ponta, H
Van Putten, WLJ
Herrlich, P
Henzen-Logmans, SC
Citation: Ja. Foekens et al., Prognostic value of CD44 variant expression in primary breast cancer, INT J CANC, 84(3), 1999, pp. 209-215
Authors:
Katagiri, YU
Sleeman, J
Fujii, H
Herrlich, P
Hotta, H
Tanaka, K
Chikuma, S
Yagita, H
Okumura, K
Murakami, M
Saiki, I
Chambers, AF
Uede, T
Citation: Yu. Katagiri et al., CD44 variants but not CD44s cooperate with beta 1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis, CANCER RES, 59(1), 1999, pp. 219-226
Authors:
Khaldoyanidi, S
Moll, J
Karakhanova, S
Herrlich, P
Ponta, H
Citation: S. Khaldoyanidi et al., Hyaluronate-enhanced hematopoiesis: Two different receptors trigger the release of interleukin-1 beta and interlenkin-6 from bone marrow macrophages, BLOOD, 94(3), 1999, pp. 940-949
Risultati:
1-22
|